Tvardi Therapeutics TVRD
NASDAQ TVRD
$1.40 0.00 (-0.36%)
As of: Nov 10, 2026 · 3:14 PM EST

Tvardi Therapeutics (TVRD) Work In Process (2021 - 2022)

Updated

Tvardi Therapeutics (TVRD) reported Work In Process of $2,000 for Q3 2022, down 99.7% from the prior quarter.

Analysis

Tvardi Therapeutics (TVRD) Work In Process (2021 - 2022) Analysis & Trends

At the end of FY2021, Tvardi Therapeutics posted Work In Process of $1.66 million.

  • Per Business Quant data, the three quarters before Q3 2022 came in at $639,000 (Q2 2022), $812,000 (Q1 2022) and $1.66 million (Q4 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Tvardi Therapeutics 12.48 Mn -95.62 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 2,000.00
Jun 30, 2022 639,000.00
Mar 31, 2022 812,000.00
Dec 31, 2021 1.66 Mn
API Access

Tvardi Therapeutics Work In Process API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=work-in-process&ticker=TVRD&period=max&api_key=YOUR_API_KEY